Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A note on rank-preserving structural failure time models to account for crossover.

Clinical trials (London, England)·2026
Same author

Real-world prescribing in accordance to ACC/AHA guidelines for lipid-lowering therapy in high-risk primary and secondary prevention of ASCVD: Real-World Prescribing for Lipid-Lowering Therapy.

American journal of preventive cardiology·2025
Same author

The comparative effectiveness of medicinal cannabis for chronic pain versus prescription medication treatment.

Pain·2025
Same author

Evaluating Meta-Learners to Analyze Treatment Heterogeneity in Survival Data: Application to Electronic Health Records of Pediatric Asthma Care in COVID-19 Pandemic.

Statistics in medicine·2025
Same author

Mediation Analysis using Semi-parametric Shape-Restricted Regression with Applications.

Sankhya. Series B. [Methodological.]·2024
Same author

Characterization and z-score calculation of cardiovascular magnetic resonance imaging parameters in patients after the Fontan operation: A Fontan Outcome Registry using Cardiovascular Magnetic Resonance Examinations study.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2024

Related Experiment Videos

Statistical analysis in cancer clinical trials.

Jong-Hyeon Jeong1

  • 1National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Anti-Cancer Drugs
|June 24, 2008
PubMed
Summary

For postmenopausal women with early breast cancer, exemestane shows promise as a valuable treatment option after 5 years of tamoxifen therapy, improving relapse-free survival.

Related Experiment Videos

Area of Science:

  • Oncology
  • Clinical Trials
  • Pharmacology

Background:

  • Tamoxifen is a standard treatment for early breast cancer, but long-term efficacy suggests a need for alternative therapies.
  • Aromatase inhibitors have emerged as effective agents, prompting re-evaluation of existing treatment guidelines and clinical trial protocols.

Purpose of the Study:

  • To evaluate the efficacy of exemestane in postmenopausal women with early breast cancer who have completed 5 years of tamoxifen therapy.
  • To determine if exemestane improves relapse-free survival in this patient population.

Main Methods:

  • The National Surgical Adjuvant Breast and Bowel Project B-33 study was unblinded early based on interim efficacy analysis.
  • Participants received exemestane after completing 5 years of tamoxifen therapy.

Main Results:

  • The study demonstrated a statistically significant improvement in relapse-free survival.
  • Exemestane was identified as a valuable treatment option for the studied patient group.

Conclusions:

  • Extended adjuvant therapy with exemestane is beneficial for postmenopausal women with early breast cancer who remain disease-free after 5 years of tamoxifen.
  • The findings support the use of aromatase inhibitors as a subsequent treatment option following tamoxifen therapy.